Arthur Tinkelenberg

Arthur Tinkelenberg is an accomplished life science executive with over 25 years of experience in various aspects of the industry, including research, operations, business development, and corporate finance. He is the Principal Owner of OurPlanet LLC, a consulting firm focused on strategy in the life sciences sector, which is not investment-related.14

Professional Background

Dr. Tinkelenberg has held significant leadership roles throughout his career. He was previously the President and Chief Operating Officer of Ceramedix, a company that developed innovative antibodies for treating organ failure. His leadership at Ceramedix included successful interactions with the FDA and managing significant research funding from the NIAID and the Department of Defense.1 Additionally, he served as the founding CEO of Enumeral, overseeing the development of an antibody pipeline and immune profiling technologies.1

Earlier in his career, Dr. Tinkelenberg was a Partner at Ascent Biomedical Ventures, where he led investments in early-stage biotech companies and provided strategic guidance to portfolio firms.1 His academic credentials include a Ph.D. in molecular genetics from The Rockefeller University and a B.A. in Biology from Grinnell College.1

Current Roles

In addition to his role at OurPlanet LLC, Dr. Tinkelenberg is actively involved in the life sciences community as a member of the Board of Directors for NewYorkBIO, an organization advocating for the life sciences industry in New York State.3 He also serves on the Board of Advisors for Life Science Cares, which aims to combat poverty through community engagement and support from industry leaders.2

Dr. Tinkelenberg's extensive experience and leadership roles reflect his commitment to advancing health innovation and improving patient outcomes through strategic initiatives within the life sciences sector.